Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

XOMA Royalty (XOMA) Research & Development (2016 - 2025)

Historic Research & Development for Royalty (XOMA) over the last 10 years, with Q3 2025 value amounting to $69000.0.

  • Royalty's Research & Development fell 9155.45% to $69000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 1272.1%. This contributed to the annual value of $2.9 million for FY2024, which is 191048.95% up from last year.
  • Royalty's Research & Development amounted to $69000.0 in Q3 2025, which was down 9155.45% from $69000.0 recorded in Q2 2025.
  • Royalty's Research & Development's 5-year high stood at $1.3 million during Q1 2025, with a 5-year trough of $25000.0 in Q3 2023.
  • For the 5-year period, Royalty's Research & Development averaged around $251210.5, with its median value being $42000.0 (2021).
  • Examining YoY changes over the last 5 years, Royalty's Research & Development showed a top increase of 381818.18% in 2025 and a maximum decrease of 9405.68% in 2025.
  • Royalty's Research & Development (Quarter) stood at $42000.0 in 2021, then crashed by 33.33% to $28000.0 in 2022, then decreased by 10.71% to $25000.0 in 2023, then skyrocketed by 3356.0% to $864000.0 in 2024, then crashed by 92.01% to $69000.0 in 2025.
  • Its Research & Development stands at $69000.0 for Q3 2025, versus $69000.0 for Q2 2025 and $1.3 million for Q1 2025.